What is the most anticipated change induced by treatment using gender‐affirming hormones in individuals with gender incongruence?
Authors:
- 19 January 2021
- journal article
- research article
- Published by Wiley in International Journal of Urology
- Vol. 28 (5) , 526-529
Abstract
Objectives: To identify the most eagerly anticipated change resulting from hormone therapy using gender‐affirming hormones for patients with gender incongruence undergoing a clinical trial.Methods: Patients diagnosed with gender identity disorders based on the International Classification of Diseases 10th revision classification at three institutions in Japan for whom hormone therapy using gender‐affirming hormones was initiated were analyzed. They were asked what the most anticipated change was due to gender‐affirming hormone that they had thought of between giving informed consent and the first administration of the drug.Results: The responders were 336 transgender men who were administered androgens and 48 transgender women who received estrogens. The median age at commencement of hormone therapy was 24 years for transgender men and 28 years for transgender women. For transgender men, the most frequent answer was cessation of menses (52.7%) followed by a deepened voice (32.4%). For transgender women, breast development (35.4%) was the most anticipated change, followed by gynoid fat deposition (29.2%).Conclusions: Cessation of menses in transgender men and breast development/gynoid fat deposition in transgender women might represent primary end‐points in clinical trials evaluating the efficacy of hormonal treatment in these patients.Keywords
This publication has 15 references indexed in Scilit:
- Voice deepening under testosterone treatment in female-to-male gender dysphoric individualsEuropean Archives of Oto-Rhino-Laryngology, 2015
- Endocrine care of transpeople part II. A review of cross‐sex hormonal treatments, outcomes and adverse effects in transwomenClinical Endocrinology, 2015
- Endocrine care of transpeople part I. A review of cross‐sex hormonal treatments, outcomes and adverse effects in transmenClinical Endocrinology, 2015
- Medical Treatment of Subjects with Gender Identity Disorder: The Experience in an Italian Public Health CenterInternational Journal of Transgenderism, 2014
- Status of sex reassignment surgery for gender identity disorder in JapanInternational Journal of Urology, 2012
- Is Hormonal Therapy Associated with Better Quality of Life in Transsexuals? A Cross-Sectional StudyThe Journal of Sexual Medicine, 2012
- Sexual dimorphism of body compositionBest Practice & Research Clinical Endocrinology & Metabolism, 2007
- Female-to-male transgender quality of lifeQuality of Life Research, 2006
- Endocrine Treatment of Transsexual People: A Review of Treatment Regimens, Outcomes, and Adverse EffectsThe Journal of Clinical Endocrinology & Metabolism, 2003
- Physical and hormonal evaluation of transsexual patients: A longitudinal studyArchives of Sexual Behavior, 1986